These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 16407823)

  • 1. A crosstalk between the Wnt and the adhesion-dependent signaling pathways governs the chemosensitivity of acute myeloid leukemia.
    De Toni F; Racaud-Sultan C; Chicanne G; Mas VM; Cariven C; Mesange F; Salles JP; Demur C; Allouche M; Payrastre B; Manenti S; Ysebaert L
    Oncogene; 2006 May; 25(22):3113-22. PubMed ID: 16407823
    [TBL] [Abstract][Full Text] [Related]  

  • 2. TRIM31 promotes acute myeloid leukemia progression and sensitivity to daunorubicin through the Wnt/β-catenin signaling.
    Xiao Y; Deng T; Ming X; Xu J
    Biosci Rep; 2020 Apr; 40(4):. PubMed ID: 32232394
    [TBL] [Abstract][Full Text] [Related]  

  • 3. c-Jun N-terminal kinase activation failure is a new mechanism of anthracycline resistance in acute myeloid leukemia.
    Lagadinou ED; Ziros PG; Tsopra OA; Dimas K; Kokkinou D; Thanopoulou E; Karakantza M; Pantazis P; Spyridonidis A; Zoumbos NC
    Leukemia; 2008 Oct; 22(10):1899-908. PubMed ID: 18650843
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Sex differences in the GSK3β-mediated survival of adherent leukemic progenitors.
    Bertrand J; Despeaux M; Joly S; Bourogaa E; Gallay N; Demur C; Bonnevialle P; Louache F; Maguer-Satta V; Vergnolle N; Payrastre B; Racaud-Sultan C
    Oncogene; 2012 Feb; 31(6):694-705. PubMed ID: 21725365
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Musashi-2 Silencing Exerts Potent Activity against Acute Myeloid Leukemia and Enhances Chemosensitivity to Daunorubicin.
    Han Y; Ye A; Zhang Y; Cai Z; Wang W; Sun L; Jiang S; Wu J; Yu K; Zhang S
    PLoS One; 2015; 10(8):e0136484. PubMed ID: 26308531
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Tunneling nanotube (TNT) formation is downregulated by cytarabine and NF-κB inhibition in acute myeloid leukemia (AML).
    Omsland M; Bruserud Ø; Gjertsen BT; Andresen V
    Oncotarget; 2017 Jan; 8(5):7946-7963. PubMed ID: 27974700
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Development and molecular characterization of polymeric micro-nanofibrous scaffold of a defined 3-D niche for in vitro chemosensitivity analysis against acute myeloid leukemia cells.
    Nair MS; Mony U; Menon D; Koyakutty M; Sidharthan N; Pavithran K; Nair SV; Menon KN
    Int J Nanomedicine; 2015; 10():3603-22. PubMed ID: 26028971
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Targeted inhibition of ULK1 enhances daunorubicin sensitivity in acute myeloid leukemia.
    Qiu L; Zhou G; Cao S
    Life Sci; 2020 Feb; 243():117234. PubMed ID: 31887299
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Human stem cell factor-antibody [anti-SCF] enhances chemotherapy cytotoxicity in human CD34+ resistant myeloid leukaemia cells.
    Lu C; Hassan HT
    Leuk Res; 2006 Mar; 30(3):296-302. PubMed ID: 16112192
    [TBL] [Abstract][Full Text] [Related]  

  • 10. HMGA2 regulates acute myeloid leukemia progression and sensitivity to daunorubicin via Wnt/β-catenin signaling.
    Yang S; Gu Y; Wang G; Hu Q; Chen S; Wang Y; Zhao M
    Int J Mol Med; 2019 Aug; 44(2):427-436. PubMed ID: 31173171
    [TBL] [Abstract][Full Text] [Related]  

  • 11. HDAC8 promotes daunorubicin resistance of human acute myeloid leukemia cells via regulation of IL-6 and IL-8.
    Wu J; Zhang L; Feng Y; Khadka B; Fang Z; Liu J
    Biol Chem; 2021 Mar; 402(4):461-468. PubMed ID: 33938176
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Lithium activates the Wnt and phosphatidylinositol 3-kinase Akt signaling pathways to promote cell survival in the absence of soluble survival factors.
    Sinha D; Wang Z; Ruchalski KL; Levine JS; Krishnan S; Lieberthal W; Schwartz JH; Borkan SC
    Am J Physiol Renal Physiol; 2005 Apr; 288(4):F703-13. PubMed ID: 15572521
    [TBL] [Abstract][Full Text] [Related]  

  • 13. PTH/cAMP/PKA signaling facilitates canonical Wnt signaling via inactivation of glycogen synthase kinase-3beta in osteoblastic Saos-2 cells.
    Suzuki A; Ozono K; Kubota T; Kondou H; Tachikawa K; Michigami T
    J Cell Biochem; 2008 May; 104(1):304-17. PubMed ID: 17990294
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Secreted frizzled-related protein-1 inhibits RANKL-dependent osteoclast formation.
    Häusler KD; Horwood NJ; Chuman Y; Fisher JL; Ellis J; Martin TJ; Rubin JS; Gillespie MT
    J Bone Miner Res; 2004 Nov; 19(11):1873-81. PubMed ID: 15476588
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Anti-apoptotic ARC protein confers chemoresistance by controlling leukemia-microenvironment interactions through a NFκB/IL1β signaling network.
    Carter BZ; Mak PY; Chen Y; Mak DH; Mu H; Jacamo R; Ruvolo V; Arold ST; Ladbury JE; Burks JK; Kornblau S; Andreeff M
    Oncotarget; 2016 Apr; 7(15):20054-67. PubMed ID: 26956049
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Increase sensitivity to chemotherapeutical agents and cytoplasmatic interaction between NPM leukemic mutant and NF-kappaB in AML carrying NPM1 mutations.
    Cilloni D; Messa F; Rosso V; Arruga F; Defilippi I; Carturan S; Catalano R; Pautasso M; Panuzzo C; Nicoli P; Messa E; Morotti A; Iacobucci I; Martinelli G; Bracco E; Saglio G
    Leukemia; 2008 Jun; 22(6):1234-40. PubMed ID: 18401421
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hammada scoparia flavonoids and rutin kill adherent and chemoresistant leukemic cells.
    Bourogaa E; Bertrand J; Despeaux M; Jarraya R; Fabre N; Payrastre L; Demur C; Fournié JJ; Damak M; Feki AE; Racaud-Sultan C
    Leuk Res; 2011 Aug; 35(8):1093-101. PubMed ID: 21216465
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Increased pressure alters plasma membrane dynamics and renders acute myeloid leukemia cells resistant to daunorubicin.
    Nirmalanandhan VS; Hurren R; Cameron WD; Gronda M; Shamas-Din A; You L; Minden MD; Rocheleau JV; Schimmer AD
    Haematologica; 2015 Oct; 100(10):e406-8. PubMed ID: 26185171
    [No Abstract]   [Full Text] [Related]  

  • 19. Chemosensitization by 4-hydroxyphenyl retinamide-induced NF-κB inhibition in acute myeloid leukemia cells.
    Zhang H; Xu H; Zhang R; Zhao X; Liang M; Wei F
    Cancer Chemother Pharmacol; 2020 Aug; 86(2):257-266. PubMed ID: 32696214
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A New alpha5beta1 integrin-dependent survival pathway through GSK3beta activation in leukemic cells.
    De Toni-Costes F; Despeaux M; Bertrand J; Bourogaa E; Ysebaert L; Payrastre B; Racaud-Sultan C
    PLoS One; 2010 Mar; 5(3):e9807. PubMed ID: 20352103
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.